The Drug Enforcement Administration has contacted 25 “designated participants” to testify at a Dec. 2 hearing about marijuana ...

The Controlled Substances Act also requires clinicians obtain a separate DEA registration in each state where their patients are located. Congress expected the DEA to issue the special ...

the US Drug Enforcement Administration (DEA) announced plans to hold an administrative hearing on its proposal to move “marijuana” from Schedule I of the Controlled Substances Act — the most ...

Though there are three criteria for Schedule I in the Controlled Substances Act, the DEA in fact relies on only the medical use criterion. This was the basis of the DEA’s proposal to reschedule ...

The Drug Enforcement Administration announced in early 2024 that it would act on President Joe Biden's call to reclassify ...

(THE CONVERSATION/AP) - The Drug Enforcement Administration announced in early 2024 that it would act on President Joe Biden’s call to reclassify marijuana, moving it from the tightly controlled ...

Village Farms International will represent the cannabis industry in the DEA hearing on marijuana rescheduling, the only ...

The settlement resolves the allegations Covetrus violated the Controlled Substances Act and other related regulations.

“The DEA is committed to ensuring that all registrants are in compliance with the required regulations, which are enforceable through the Controlled Substances Act,” said DEA Acting Special ...

Though there are three criteria for Schedule I in the Controlled Substances Act, the DEA in fact relies on only the medical use criterion. This was the basis of the DEA’s proposal to reschedule ...

The Drug Enforcement Administration announced in early 2024 that it would act on President Joe Biden’s call to reclassify marijuana, moving it from the tightly controlled Schedule I category ...